mt
stringlengths 1
3.29k
| en
stringlengths 1
3.45k
|
|---|---|
INTERESSI FUQ ARRETRATI U MULTI | INTEREST ON LATE PAYMENTS AND FINES |
Komuni: | Common: |
Studji fuq il-bhejjem ma jurux effetti ta' ħsara diretti fuq it-tqala, ħlas jew żvilupp wara t-twelid. | Animal studies do not indicate direct harmful effects with respect to pregnancy, parturition or postnatal development. |
Tagħzel id-doża | Select the dose |
ĠU L 229, 9.9.2000, p. 14; Edizzjoni Speċjali bil-Malti: Kapitolu 11 Volum 34 p. 84. | OJ L 229, 9.9.2000, p. 14. |
- iżżid it-trasport tal-glucose ġewwa ċ-ċelluli kif ukoll l-produzzjoni tal-glikoġen fil-muskoli u l- | - increases the transport of glucose into cells as well as the formation of glycogen in the muscles and |
mara. | female. |
0. 0101 | 0.0101 |
Mhux f'koljaturi, mhux maħdumin iktar ħlief irrumblati fil-kiesaħ (imnaqqsin bla sħana) | Not in coils, not further worked than cold-rolled (cold-reduced) |
Alkoħol: jista' jkun hemm żieda fil-pressjoni baxxa ortostatika; | 57 Alcohol: potentiation of orthostatic hypotension may occur; |
Ir-rakkomandazzjonijiet huma kif dikjarati fuq għall-adulti. | Recommendations are as stated above for adults. |
30 11 | 30 11 |
Artikolu 1 | Article 1 |
6. 6 Prekawzjonijiet speċjali li għandhom jittieħdu meta jintrema | 6.6 Special precautions for disposal |
Il-portijiet Kroati ta' Rijeka u Split kienu portijiet tradizzjonali ta' ħruġ għall-pajjiżi tal-Ewropa ċentrali qabel l-adeżjoni tagħhom mal-Unjoni. | The Croatian ports of Rijeka and Split were traditional ports of exit for the countries of central Europe before their accession to the Union. |
Magħmul fi Brussell, is-16 ta' Ottubru 2009. | Done at Brussels, 16 October 2009. |
Dan ifisser li Pegasys huwa injettat b'labra qasira fit-tessut xaħmi ta' taħt il-ġilda fl-addome jew fil-koxxa. | This means that Pegasys is injected with a short needle into the fatty tissue under the skin in the abdomen or thigh. |
Inklina l-qiegħ ta' wara'l quddiem mal-waqfa ta' quddiem u iġbed il-magna 3-D H'il bogħod mid-dahar tas-sit permezz tat-T-bar. | Tilt the back pan forward against the forward stop and draw the 3-D H machine away from the seat-back using the T-bar. |
Dawn il-prodotti jeħtiġilhom ukoll jissodisfaw l-esiġenzi tar-Regolament (KE) Nru 852/2004 tal-Parlament Ewropew u tal-Kunsill tad-29 ta' April 2004 dwar l-iġjene tal-oġġetti tal-ikel [3]. | Those products should also comply with the requirements of Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of foodstuffs [3]. |
GĦAMLA FARMAĊEWTIKA U KONTENUT | PHARMACEUTICAL FORM AND CONTENTS |
DISPOSIZZJONIJIET DWAR IR-RISTRUTTURAR TA' L-INDUSTRIJA ĊEKA TA' L-AZZAR | PROVISIONS ON THE RESTRUCTURING OF THE CZECH STEEL INDUSTRY |
Il-linji gwida skont attività speċifika f'dan l-Anness għandhom jintużaw għall-monitoraġġ u r-rappurtar tal-emissjonijiet minn attivitajiet tal-avjazzjoni elenkati fl-Anness I tad-Direttiva 2003/87/KE. | The activity-specific guidelines in this Annex shall be used to monitor and report emissions occurring from aviation activities as listed in Annex I to Directive 2003/87/EC. |
Għaldaqstant il-kejl tal-livelli ta' IgE ma jistgħux jintużaw bħala gwida sabiex tkun deċiża d-doża li għandha tingħata. | Therefore, re-testing of IgE levels during Xolair treatment cannot be used as a guide for dose determination. |
għall-użu fil-manifattura ta' pannelli ta' ċirkwiti stampati [1] | for use in the manufacture of printed circuit boards [1] |
Eċċezzjonali | Exceptional |
Kittien | Linseed |
diffikultajiet involuti fl-infurzar ta' dawk il-liġijiet, regolamenti jew dispożizzjonijiet amministrattivi. | difficulties involved in the enforcement of those laws, regulations and administrative provisions. |
- Jekk xi wieħed mill-effetti sekondarji jiggrava, jew jekk tinnota xi effetti sekondarji li | - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, |
2 pilloli li jerħu l-mediċina b'mod modifikat 4 pilloli li jerħu l-mediċina b'mod modifikat 7 pilloli li jerħu l-mediċina b'mod modifikat 10 pilloli li jerħu l-mediċina b'mod modifikat 14- il pillola li jerħu l-mediċina b'mod modifikat 20 pillola li jerħu l-mediċina b'mod modifikat | 2 modified-release tablets 4 modified-release tablets 7 modified-release tablets 10 modified-release tablets 14 modified-release tablets 20 modified-release tablets |
Diviżjonijiet tal-Opposizzjoni | Opposition Divisions |
Pregabalin ġie studjat f'6 studji kkontrollati li damu 4- 6 ġimgħat, studju fost l-anzjani li dam 8 ġimgħat u studju fuq perijodu fit-tul dwar il-prevenzjoni tal-ħruġ mill-ġdid tal-marda b'fażi double blind ta'prevenzjoni tal-ħruġ mill-ġdid tal-marda li damet 6 xhur. | Pregabalin has been studied in 6 controlled studies of 4-6 week duration, an elderly study of 8 week duration and a long-term relapse prevention study with a double blind relapse prevention phase of 6 months duration. |
ta' kwalità baxxa | low quality |
Fid-distrett ta' Rugāju, il-muniċipalitajiet ta' Rugāju u Lazdukalna. | In the novads of Rugāju the pagasti of Rugāju and Lazdukalna. |
Kapitolu 3 2 — Total | Chapter 3 2 — Total |
Kwalunkwe deċiżjoni provviżorja jew finali tal-bord tal-arbitraġġ għandha torbot lill-Partijiet. | Any provisional decision or final decision of the arbitration panel shall be binding upon the Parties. |
Il-kumpanija li tikkummerċjalizzah hija Sanofi- aventis | The company that markets it is Sanofi-aventis |
Filwaqt li hemm diffikultà akbar fl-allokazzjoni tar-rekwiżiti ta' fondi proprji għar-riskju operazzjonali fil-livell tal-iskopertura individwali u għalhekk jixraq li din il-kategorija tar-riskji tiġi eskluża mill-proċess ta' valutazzjoni komparattiva, l-awtoritajiet kompetenti għandhom madankollu jżommu ruħhom aġġornati rigward l-iżviluppi fl-approċċi ta' mudellar interni għar-riskju operazzjonali, bl-għan li jissorveljaw il-firxa ta' prattiki użati u jtejbu l-approċċi superviżorji. | While own funds requirements for operational risk are more difficult to allocate at individual exposure level and it is therefore appropriate to exclude this risk category from the benchmarking process, competent authorities should nevertheless keep abreast of developments in internal modelling approaches to operational risk, with the aim of monitoring the range of practices employed and improving supervisory approaches. |
Minħabba xebh ma' emtricitabine, Atripla m'għandhiex tingħata fl-istess ħin ma' analogi cytidine oħra, bħal lamivudine (ara sezzjoni 4. 5). | Due to similarities with emtricitabine, Atripla should not be administered concomitantly with other cytidine analogues, such as lamivudine (see section 4.5). |
ĠU L 299, 16.11.2007, p. 1. | OJ L 299, 16.11.2007, p. 1. |
Effetti sekondarji komuni: jaffettwaw 1 sa 10 minn kull 100 pazjent • Tibdil fil-livelli ta'xi ċelluli tad-demm u xaħmijiet fid-demm. • Żidiet fil-livelli ta' zokkor fid-demm u fl-awrina. • Tħossok aktar bil-ġuħ. • Sturdament. • Irrekwjetezza. • Rogħda. • Ebusija tal-muskoli jew spażmi (inklużi movimenti fl-għajnejn). • Problemi fil-mod kif titkellem. • Moviment mhux tas-soltu (speċjalment tal-wiċċ jew ta' l-ilsien). • Stitikezza. • Ħalq xott. • Raxx. • Titlef il-forzi. • Għeja eżaġerata. • Retenzjoni ta'l- ilma li twassal għal nefħa fl-idejn, għekiesi jew saqajn. • Fl-ewwel stadji tal-kura, xi persuni jistgħu jħossuhom sturduti jew mhux f'sikkithom (il- qalb tħabbat bil-mod), speċjalment waqt li jkunu qegħdin iqumu minn pożizzjoni mimduda jew minn bilqiegħda. | Common side effects: affect 1 to 10 users in 100 • Changes in the levels of some blood cells and circulating fats. • Increases in the level of sugars in the blood and urine. • Feeling more hungry. • Dizziness. • Restlessness. • Tremor. • Muscle stiffness or spasm (including eye movements). • Problems with speech. • Unusual movement (especially of the face or tongue). • Constipation. • Dry mouth. • Rash. • Loss of strength. • Extreme tiredness. • Water retention leading to swelling of the hands, ankles or feet. • In the early stages of treatment, some people may feel dizzy or faint (with a slow heart rate), especially when getting up from a lying or sitting position. |
Kull fdal tal-prodott li ma jkunx intuża jew skart li jibqa' wara l-użu tal-prodott għandu jintrema kif jitolbu l-liġijiet lokali. | Any unused product or waste material should be disposed of in accordance with local requirements. |
Bank Pocztowy S.A. li 75 % minnu jappartjeni lil PP (minn hawn'il quddiem BP), | Bank Pocztowy S.A. which is 75 % owned by PP (hereinafter'BP'), |
Aħżen fi friġġ (2°C - 8°C). | Store in a refrigerator (2°C - 8°C). |
1. | 1. |
Noċimuskata | Nutmeg |
Id-daqs tal-bidliet fil-livelli tal-lipidi jista' jkun influwenzat minn fatturi bħal m'huma t-tul tal-kura u komponenti oħra fil-kura antiretrovirali. | The magnitude of changes in lipid levels may be influenced by factors such as duration of therapy and other components of the antiretroviral regimen. |
Εθνικής Οδού Αθηνών- Λαμίας GR-144 51, Μεταμόρφωση Αττικής Τηλ: + 30 210 2812640 | Εθνικής Οδού Αθηνών -Λαμίας GR-144 51, Μεταμόρφωση Αττικής Τηλ: + 30 210 2812640 |
L-ewwel simptomi ta' stimulazzjoni eċċessiva huma wġigħ fil-parti t' isfel ta' l-addome, possibilment ma' nawsea, remettar u zieda fil-piz. | First symptoms of ovarian hyperstimulation are pain in the lower abdominal region, possibly in combination with nausea, vomiting and weight gain. |
Informazzjoni pri- klinika ma wrietx ebda riskju speċjali għan-nies bażata fuq studji konvenzjonali ta' sigurtà farmakoloġika, tossisità ta' doża ripetuta, ġenotossiċità, potenzjal karċinoġeniku, u ħsara fis-sistema riproduttiva. | Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, and toxicity to reproduction. |
(test wieħed) | (one test) |
Artikolu 1 | Article 1 |
2. | 2. |
ĠU L 49, 19.2.2004,p. 1. | OJ L 49, 19.2.2004, p. 1. |
Magħmul fi Brussell, id-9 ta' Lulju 2013. | Done at Brussels, 9 July 2013. |
Membru tal-Kummissjoni | Member of the Commission |
Il-kumpanija tal-investiment taż-ZANU-PF. | ZANU-PF's investment company. |
FAEG – 25 % miżmuma mill-ammonti minħabba kundizzjonalità (R1782/2003, Art. 9) | EAGF – 25 % retention on amounts resulting from cross-compliance (R1782/2003, Art. 9) |
IL-KUNSILL TAL-UNJONI EWROPEA, | THE COUNCIL OF THE EUROPEAN UNION, |
M'għandekx tuża IntronA jekk tinnota xi tibdil fid-dehra ta' IntronA. | Do not use IntronA if you notice changes in the appearance of IntronA. |
L-interventi tal-kambju barrani tal-Eurosistema | The Eurosystem's foreign exchange interventions |
Wara l-impatt, it-trażżin għat-tfal għandu jiġi spezzjonat viżwalment, mingħajr ma tinfetaħ il-bokkla, biex jiġi determinat jekk kienx hemm xi ħsara. | After impact, the child restraint shall be inspected visually, without opening the buckle, to determine whether there has been any failure. |
Operatur bil-kodiċi TAIL NB:V2LDL | Operator using TAIL NB:V2LDL |
Għall-finijiet tal-punt (c) tal-Artikolu 58(3), l-operatur jew l-operatur tal-inġenji tal-ajru għandu jassenja persuni responsabbli għall-attivitajiet kollha ta' fluss ta' dejta u għall-attivitajiet kollha ta' kontroll b'mod li jissepara d-dmirijiet konflittwali. | For the purposes of point (c) of Article 58(3), the operator or aircraft operator shall assign responsible persons for all data flow activities and for all control activities in a way to segregate conflicting duties. |
L-istaġun magħluq għas-sajd | Closed fishing season |
Fejn issir referenza għal dan il-punt, għandu japplika l-Artikolu 5 tar-Regolament (UE) Nru 182/2011. | Where reference is made to this point, Article 5 of Regulation (EU) No 182/2011 shall apply. |
Meta l-kura b'DULOXETINE BOEHRINGER INGELHEIM tkun ser titwaqqaf id-doża għandha tiġi mnaqqsa gradwalment fuq perijodu ta' mill-anqas ġimgħa sa ġimagħtejn sabiex jitnaqqas ir-riskju ta' reazzjonijiet ta' rtirar (ara sezzjonijiet 4. 4 u 4. 8). | When stopping treatment with DULOXETINE BOEHRINGER INGELHEIM the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see sections 4.4 and 4.8). |
EDUKAZZJONI U KULTURA | EDUCATION AND CULTURE |
Newtropenja, tromboċitopenja jew l-anemija riversibbli żviluppaw fi ftit klieb ittrattati b'8 jew 10 mg/ kg/ ġurnata (espożizzjoni totali ta' olanzapine [erja taħt il-kurva] hija 12 sa 15- il darba aktar minn dik ta'raġel mogħti doża ta' 12 mg). | Reversible neutropenia, thrombocytopenia, or anemia developed in a few dogs treated with 8 or 10 mg/ kg/ day (total olanzapine exposure [AUC] is 12- to 15-fold greater than that of a man given a 12-mg dose). |
Wara li kkunsidra t-Trattat dwar l-Unjoni Ewropea, u b'mod partikolari t-tieni paragrafu tal-Artikolu 38 tiegħu, | Having regard to the Treaty on European Union, and in particular Article 38, second paragraph, thereof, |
ġew trasportati mill-istabbilimenti tagħhom sa biċċerija approvata f'vetturi mnaddfa u ddiżinfettati qabel it-tagħbija, mingħajr kuntatt ma' annimali oħra li ma kinux konformi mal-kondizzjonijiet stipulati fil-punti II.2.1, II.2.2 u II.2.3 | have been transported from their holdings in vehicles, cleaned and disinfected before loading, to an approved slaughterhouse without contact with other animals which did not comply with the conditions set out in points II.2.1, II.2.2 and II.2.3, |
Terminu riżervat għad-DPO'Madeira', inbid li jiġi ffortifikat wara l-fermentazzjoni u jinħażen f'bettija, jitqaddem għal perjodu minimu ta' sentejn, u għandu jidher f'reġistru kurrenti speċifiku. Ma jistax jiġi bbottiljat qabel tliet snin. | Term reserved for “Madeira” PDO wine which is fortified after fermentation and stored in cask, aged for a minimal period of two years, and must appear on a specific current account and cannot be bottled with less than three years. |
Il-garanti għandu jkun approvat mill-awtoritajiet doganali li jeħtieġu l-garanzija, sakemm il-garanti ma jkunx istituzzjoni ta' kreditu, istituzzjoni finanzjarja jew kumpanija tal-assikurazzjoni, akkreditata fl-Unjoni skont il-provvedimenti tal-Unjoni fis-seħħ. | The guarantor shall be approved by the customs authorities requiring the guarantee, unless the guarantor is a credit institution, financial institution or insurance company accredited in the Union in accordance with Union provisions in force. |
5. | 5. |
Wara li kkunsidrat ir-Regolament (UE) Nru 1151/2012 tal-Parlament Ewropew u tal-Kunsill tal-21 ta' Novembru 2012 dwar skemi tal-kwalità għal prodotti agrikoli u oġġetti tal-ikel [1], u partikolarment l-Artikolu 52(2) tiegħu, | Having regard to Regulation (EU) No 1151/2012 of the European Parliament and of the Council of 21 November 2012 on quality schemes for agricultural products and foodstuffs [1], and in particular Article 52(2) thereof, |
Wejfer ta' nijobat tal-lizju, mhux miżjud | Lithium niobate wafer, undoped |
Mhux applikabbli: l-applikazzjonijiet ma jaqbżux il-kwantitajiet disponibbli u qed jingħataw kollha. | Not applicable: the applications do not exceed the quantities available and are fully granted. |
fl-Artikolu 94(1), it-tieni subparagrafu għandu jinbidel b'dan li ġej: | in Article 94(1), the second subparagraph is replaced by the following: |
Operazzjonijiet bir-RVSM | RVSM operations |
Espożizzjoni għal terapija AIIRAs matul it-tieni u t-tielet trimestri hija magħrufa li twassal għal tossiċità tal-fetu uman (tnaqqis fil-funzjoni tal-kliewi, oligohydramnios, tnaqqis fl-ossifikazzjoni tal-għadam tar-ras) u tossiċità neonatali (nuqqas fil-funzjoni tal-kliewi, pressjoni baxxa, iperkalemija) (ara sezzjoni 5. 3). | (see section 5.3). |
Dan ifisser li għal raġunijiet xjentifiċi ma kienx possibbli li tinkiseb informazzjoni kompleta dwar dan il-prodott mediċinali. | This means that for scientific reasons it has not been possible to obtain complete information on this medicinal product. |
Segwi l-parir tag hom bl-attenzjoni. | Follow their advice carefully. |
130 µg | 130 µg |
1, 3, 5 | 1, 3, 5 |
ANNESS III | ANNEX III |
L-alluċinazzjonijiet kienu rrappurtati u l-pazjenti għandhom ikunu infurmati li l-alluċinazzjonijiet jistgħu jseħħu. | Hallucinations have been reported and patients should be informed that hallucinations can occur. |
Il-fond għall-mard tal-annimali tar-reġjun tal-Bavarja huwa istituzzjoni tas-settur pubbliku li huwa ffinanzjat minn dazji li jixbhu lit-taxxi. | The BTSK is a public body financed by parafiscal levies. |
(ex Artikolu 25 TKE) | (ex Article 25 TEC) |
Prodotti ta' l-insulina g andhom ji u mi juda biss ma' dawk is-sustanzi li huwa mag ruf li huma kompatibbli mag hom. | Insulin products should only be added to compounds with which it is known to be compatible. |
Il-Kapijiet tad-Delegazzjonijiet tal-Unjoni għandhom ikunu responsabbli għat-twaqqif u l-funzjonament adegwat ta' dawk is-sistemi, skont l-istruzzjonijiet tal-uffiċjal awtorizzanti b'delega, u għall-ġestjoni tal-fondi u l-operazzjonijiet li dawn jeżegwixxu fid-Delegazzjoni tal-Unjoni taħt ir-responsabilità tagħhom. | The Heads of Union Delegations shall be responsible for the adequate setting up and functioning of those systems, in accordance with the instructions of the authorising officer by delegation, and for the management of the funds and the operations they carry out within the Union Delegation under their responsibility. |
ta' mnejn jingħata | Common (occurring in at least 1 of 100 but less than 1 of 10 patients) In infants/ children/ adolescents: transient local skin reactions |
Tabella 3 L-effikaċja globali ta' posaconazole fl-aħħar tal-kura għal asperġillożi invażiva imqabbla mal-grupp ta' kontroll minn barra. | Table 3. |
Tista' wkoll tgħin lill-batterja ssir reżistenti u b'hekk tittardja l-fejqan tiegħek jew tnaqqas l-effikaċja ta' l-antibijotiku jekk ma tirrispettax: dożaġġ xieraq | You may even help bacteria become resistant and therefore delay your cure or decrease antibiotic efficacy if you do not respect appropriate: |
EMEA/ CVMP/ 283947/ 2008- MT | EMEA/ CVMP/ 283947/ 2008-EN |
L-Artikoli 2 u 3(3) tat-Trattat dwar l-Unjoni Ewropea jistabbilixxu d-dritt għall-ugwaljanza bejn in-nisa u l-irġiel bħala wieħed mill-valuri u l-kompiti essenzjali tal-Unjoni. | Article 2 and Article 3(3) of the Treaty on European Union enshrine the right to equality between women and men as one of the essential values and tasks of the Union. |
Oqgħod attent ħafna b'Ciprofloxacin Bayer), jew sturdament | Take special care with Ciprofloxacin Bayer), or giddiness |
1 1. | 1 1. |
Ara n-noti ta'kawtela 1 u 2 iktar' l isfel. | See Cautionary notes 1 and 2 7 below. |
produzzjoni terzjarja | tertiary production |
Eritropoetin hija glikoproteina li tistimula, bħala fattur li jistimula l-mitosi u ormon ta' differenzjar, il-formazzjoni ta' eritroċiti minn prekursuri tal-kompartiment taċ-ċellula stem. | Erythropoietin is a glycoprotein that stimulates, as a mitosis-stimulating factor and differentiating hormone, the formation of erythrocytes from precursors of the stem cell compartment. |
Wara li kkunsidraw il-proposta mill-Kummissjoni Ewropea, | Having regard to the proposal from the European Commission, |
Subsets and Splits